Telecom Healthcare Sector

BLIS Technologies

Market Cap: NZ$17.9m

Develops and sells healthcare products based on strains of bacteria that produce bacteriocin activity.

Cyclerion Therapeutics

Market Cap: US$10.5m

A biopharmaceutical company, develops treatments for serious diseases serious diseases with novel sGC stimulators in both the central nervous system (CNS) and the periphery.

Pacific Health Care Organization

Market Cap: US$10.5m

Operates as a workers’ compensation cost containment company in the United States.

Athira Pharma

Market Cap: US$10.5m

Athira Pharma, Inc., clinical-stage biopharmaceutical company, focuses on developing small molecules to restore neuronal health and slow neurodegradation.

Emyria

Market Cap: AU$16.2m

Engages in delivering and developing of new treatments for unmet needs in mental health and select neurological conditions in Australia.

Dogwood Therapeutics

Market Cap: US$10.4m

A development-stage biotechnology company, focuses on the development of medicine to treat pain and fatigue-related disorders.

Firebrick Pharma

Market Cap: AU$16.2m

Engages in the development and commercializing of novel formulations for the uses of povidone iodine in Australia.

CareView Communications

Market Cap: US$10.4m

Operates as a video monitoring solutions provider in the United States.

OncoSil Medical

Market Cap: AU$16.1m

A medical device company, develops and commercializes localized radiation therapy for the treatment of pancreatic and distal cholangiocarcinoma in Australia, New Zealand, and Europe.

TELA Bio

Market Cap: US$10.4m

A commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient’s anatomy.

HCW Biologics

Market Cap: US$10.3m

A clinical-stage biopharmaceutical company, focuses on discovering and developing novel immunotherapies for chronic, low-grade inflammation, and age-related diseases in the United States.

Pharmala Biotech Holdings

Market Cap: CA$14.3m

Pharmala Biotech Holdings Inc., doing business as PharmAla, engages in the manufacture and sale of MDMA and MDXX class molecules in service to the burgeoning clinical research community.

Hemogenyx Pharmaceuticals

Market Cap: UK£7.7m

A clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of treatments for blood cancer.

Avecho Biotechnology

Market Cap: AU$15.8m

A biotechnology company, develops and commercializes human and animal health products using its proprietary drug delivery system, tocopherol phosphate mixture (TPM) in Australia, Switzerland, the Americas, and India.

ReNerve

Market Cap: AU$15.7m

A medical device company, develops tissue-based products for peripheral nerve repair and replacement, and other related soft tissue surgical procedures.

KRTL Holding Group

Market Cap: US$10.1m

KRTL Holding Group, Inc, a beverage and food company, engages in the production and distribution of bottled natural spring water and flavored carbonated water in North America and internationally.

SOL Global Investments

Market Cap: CA$14.0m

A private equity firm specializing in growth capital to small and mid-sized businesses.

ECS Botanics Holdings

Market Cap: AU$15.6m

Engages in the cultivation, manufacture, and sale of medicinal cannabis products in Northwest Victoria.

STRATA Skin Sciences

Market Cap: US$10.1m

A medical technology company, develops, commercializes, and markets products for the treatment of dermatologic conditions in the United States, China, Europe, the Middle East, Asia, Australia, South Africa, and Central and South America.

BioCardia

Market Cap: US$10.0m

A clinical-stage regenerative medicine company, develops cellular and cell-derived therapeutics for cardiovascular and pulmonary diseases in the United States.

Aptamer Group

Market Cap: UK£7.4m

Provides binders for research, diagnostics, and therapeutics in the United Kingdom, rest of Europe, the United States, and internationally.

Pharma-Bio Serv

Market Cap: US$9.9m

Operates as a regulatory affairs, compliance, and technology transfer services consulting firm in Puerto Rico, the United States, Europe, Brazil, and internationally.

Guided Therapeutics

Market Cap: US$9.9m

A medical technology company, develops medical devices.

Kairos Pharma

Market Cap: US$9.8m

A clinical-stage biopharmaceutical company, develops therapeutics for cancer patients.

Predictive Oncology

Market Cap: US$9.8m

A knowledge and science-driven company, applies artificial intelligence (AI) to support the discovery and development of cancer therapies.

Brainstorm Cell Therapeutics

Market Cap: US$9.8m

A biotechnology company, engages in the development and commercialization of autologous cellular therapies for the treatment of neurodegenerative diseases.

Fusion Antibodies

Market Cap: UK£7.3m

A contract research organization, engages in the research, development, and manufacture of recombinant proteins and antibodies primarily for cancer and infectious diseases in the United Kingdom, the rest of Europe, North America, and internationally.

RUA Life Sciences

Market Cap: UK£7.2m

Engages in the provision of polymers, services, and products to the medical device industry in Europe, the United States, and internationally.

DIH Holding US

Market Cap: US$9.7m

Operates as a robotics and virtual reality (VR) technology provider for the rehabilitation industry in Europe, the Middle East, Africa, the United States, and the Asia Pacific.

Inhibitor Therapeutics

Market Cap: US$9.7m

A pharmaceutical development company, develops and commercializes therapeutics for patients with certain cancers and non-cancerous proliferation disorders in the United States.

Minerva Neurosciences

Market Cap: US$9.7m

A clinical-stage biopharmaceutical company, focuses on the development and commercialization of product candidates for the treatment of central nervous system diseases.

Immuron

Market Cap: AU$15.0m

A biopharmaceutical company, engages in the research, development, and commercialization of polyclonal antibodies in Australia, the United States, and Canada.

Aprea Therapeutics

Market Cap: US$9.6m

A clinical-stage biopharmaceutical company, focuses on developing and commercializing novel synthetic lethality-based cancer therapeutics that targets DNA damage response pathways.

TruScreen Group

Market Cap: NZ$16.1m

Develops, manufacture, and sale of cancer detection devices and systems in Mexico, China, Russia, Vietnam, Zimbabwe, Eastern Europe, the Middle East/North Africa, and internationally.

NeuPath Health

Market Cap: CA$13.2m

Provides chronic pain management services in Canada.

Kiora Pharmaceuticals

Market Cap: US$9.5m

A clinical-stage specialty pharmaceutical company, engages in the development and commercialization of therapies for the treatment of ophthalmic diseases.